BACKGROUND: Anxiety, apathy and depression are common in subjects with mild cognitive impairment (MCI) and may herald Alzheimer's disease (AD). We investigated whether these symptoms correlated with cerebrospinal fluid (CSF) markers for AD in subjects with MCI. Method Subjects with MCI (n=268) were selected from the 'Development of screening guidelines and criteria for pre-dementia Alzheimer's disease' (DESCRIPA) and Alzheimer's Disease Neuroimaging Initiative (ADNI) studies. We measured amyloid β(1-42) protein (Aβ42) and total tau (t-tau) in CSF. Neuropsychiatric symptoms were measured with the Neuropsychiatric Inventory. RESULTS: Depressive symptoms were reported by 55 subjects (21%), anxiety by 35 subjects (13%) and apathy by 49 subjects (18%). The presence of anxiety was associated with abnormal CSF Aβ42 [odds ratio (OR) 2.3, 95% confidence interval (CI) 1.6-3.3] and t-tau (OR 2.6, 95% CI 1.9-3.6) concentrations and with the combination of abnormal concentrations of both Aβ42 and t-tau (OR 3.1, 95% CI 2.0-4.7). The presence of agitation and irritability was associated with abnormal concentrations of Aβ42 (agitation: OR 1.6, 95% CI 1.1-2.3; irritability: OR 2.2, 95% CI 1.5-3.3). Symptoms of depression and apathy were not related to any of the CSF markers. CONCLUSIONS: In subjects with MCI, symptoms of anxiety, agitation and irritability may reflect underlying AD pathology, whereas symptoms of depression and apathy do not.
BACKGROUND:Anxiety, apathy and depression are common in subjects with mild cognitive impairment (MCI) and may herald Alzheimer's disease (AD). We investigated whether these symptoms correlated with cerebrospinal fluid (CSF) markers for AD in subjects with MCI. Method Subjects with MCI (n=268) were selected from the 'Development of screening guidelines and criteria for pre-dementia Alzheimer's disease' (DESCRIPA) and Alzheimer's Disease Neuroimaging Initiative (ADNI) studies. We measured amyloid β(1-42) protein (Aβ42) and total tau (t-tau) in CSF. Neuropsychiatric symptoms were measured with the Neuropsychiatric Inventory. RESULTS:Depressive symptoms were reported by 55 subjects (21%), anxiety by 35 subjects (13%) and apathy by 49 subjects (18%). The presence of anxiety was associated with abnormal CSF Aβ42 [odds ratio (OR) 2.3, 95% confidence interval (CI) 1.6-3.3] and t-tau (OR 2.6, 95% CI 1.9-3.6) concentrations and with the combination of abnormal concentrations of both Aβ42 and t-tau (OR 3.1, 95% CI 2.0-4.7). The presence of agitation and irritability was associated with abnormal concentrations of Aβ42 (agitation: OR 1.6, 95% CI 1.1-2.3; irritability: OR 2.2, 95% CI 1.5-3.3). Symptoms of depression and apathy were not related to any of the CSF markers. CONCLUSIONS: In subjects with MCI, symptoms of anxiety, agitation and irritability may reflect underlying AD pathology, whereas symptoms of depression and apathy do not.
Authors: P J Visser; F R J Verhey; M Boada; R Bullock; P P De Deyn; G B Frisoni; L Frolich; H Hampel; J Jolles; R Jones; L Minthon; F Nobili; M Olde Rikkert; P-J Ousset; A-S Rigaud; P Scheltens; H Soininen; L Spiru; J Touchon; M Tsolaki; B Vellas; L-O Wahlund; G Wilcock; B Winblad Journal: Neuroepidemiology Date: 2008-06-02 Impact factor: 3.282
Authors: Yonas E Geda; Rosebud O Roberts; David S Knopman; Ronald C Petersen; Teresa J H Christianson; Vernon S Pankratz; Glenn E Smith; Bradley F Boeve; Robert J Ivnik; Eric G Tangalos; Walter A Rocca Journal: Arch Gen Psychiatry Date: 2008-10
Authors: Howard H Feldman; Steven Ferris; Bengt Winblad; Nikolaos Sfikas; Linda Mancione; Yunsheng He; Sibel Tekin; Alistair Burns; Jeffrey Cummings; Teodoro del Ser; Domenico Inzitari; Jean-Marc Orgogozo; Heinrich Sauer; Philip Scheltens; Elio Scarpini; Nathan Herrmann; Martin Farlow; Steven Potkin; H Cecil Charles; Nick C Fox; Roger Lane Journal: Lancet Neurol Date: 2007-06 Impact factor: 44.182
Authors: Rebecca Erwin Wells; Catherine Kerr; Michelle L Dossett; Suzanne C Danhauer; Stephanie J Sohl; Bonnie C Sachs; Jacquelyn Walsh Feeley; Jennifer Wolkin; Robert Wall; Ted Kaptchuk; Daniel Z Press; Russell S Phillips; Gloria Y Yeh Journal: J Alzheimers Dis Date: 2019 Impact factor: 4.472
Authors: Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Jesse Cedarbaum; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Johan Luthman; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie Shaw; Li Shen; Adam Schwarz; Arthur W Toga; John Q Trojanowski Journal: Alzheimers Dement Date: 2015-06 Impact factor: 21.566
Authors: Jennifer S Rabin; Zahra Shirzadi; Walter Swardfager; Bradley J MacIntosh; Aaron Schultz; Hyun-Sik Yang; Rachel F Buckley; Jennifer R Gatchel; Dylan Kirn; Jeremy J Pruzin; Trey Hedden; Nir Lipsman; Dorene M Rentz; Sandra E Black; Keith A Johnson; Reisa A Sperling; Jasmeer P Chhatwal Journal: Neurobiol Aging Date: 2020-03-07 Impact factor: 4.673
Authors: S Christine You; Christine M Walsh; Louis A Chiodo; Robin Ketelle; Bruce L Miller; Joel H Kramer Journal: J Alzheimers Dis Date: 2015 Impact factor: 4.472
Authors: Ganesh M Babulal; Nupur Ghoshal; Denise Head; Elizabeth K Vernon; David M Holtzman; Tammie L S Benzinger; Anne M Fagan; John C Morris; Catherine M Roe Journal: Am J Geriatr Psychiatry Date: 2016-04-19 Impact factor: 4.105